Acta Scientific Pharmacology (ASPC)

Case Report Volume 1 Issue 4

A Case Presentation on Chloramphenicol Induced Pancytopenia

Saidulu Ghanta*, Niharika and Narmada

Department of Infectious Diseases, Yashoda Hospitals Secunderabad, India

*Corresponding Author: Saidulu Ghanta, Department of Infectious Diseases, Yashoda Hospitals Secunderabad, India.

Received: February 18, 2020; Published: March 20, 2020

×

Abstract

Background: Chloramphenicol is a semi synthetic, broad spectrum antibiotic derived from Streptomyces venezualae with bacteriostatic activity as it inhibits bacterial protein synthesis.

  We report an adverse drug reaction chloramphenicol induced pancytopenia in a patient with severe traumatic brain injury caused by road traffic accident, treatment was initiated based on literature analysis.

Case Presentation: We report a case with chloramphenicol induced pancytopenia in a patient with severe traumatic brain injury due to road traffic accident. He acquired Multi drug resistant Klebsiella pneumoniae. Chloramphenicol was initiated which caused pancytopenia.

Keywords: Hypertension; Obesity; Type-2 Diabetes; Metabolic Diseases

×

References

  1. Pooja Shukla., et al. “Chloramphenicol Toxicity: A Review”. Journal of Medicine and Medical Sciences 2.13 (2011): 1313-1316.
  2. Rich ML., et al. “A fatal case of aplastic anemia following chloramphenicol (chloromycetin) therapy”. Annals of Internal Medicine 33 (150): 1459-1467.
  3. Ambeker CE., et al. “Metabolism of chloramphenicol succinate in human bone marrow”. European Journal of Clinical Pharmacology 56 (2000): 405-409.
  4. Rich ML., et al. “A fatal case of aplastic anemia following chloramphenicol therapy”. Annals of Internal Medicine 33 (1950): 1459.
  5. Thomas B Casale., et al. “Complete hematologic and hepatic recovery in a patient with chloramphenicol hepatitis-pancytopenia syndrome”. Journal of Pediatrics 101 (1982).
  6. M Aksoy., et al. “Aplastic anemia due to chemicals and drugs: a study of 108 patients”. Sexually Transmitted Disease 11.4 (1984): 347-350.
  7. R Andrews and N Russell. “Aplastic anemia associated with a non-steroidal anti-inflammatory drug: relapse after exposure to another such drug”. British Medical Journal 301 (1990): 38.
  8. MN Alnigenis., et al. “Possible etiologic factors in 151 Turkish patients with aplastic anemia”. American Journal of Hematology 68.1 (2001): 60-61.
  9. E Baumelou., et al. “Epidemiology of aplastic anemia in France: a case-control study”. Blood 81.6 (1993): 1471-1478.
  10. Man-yan., et al. “Comparative metabolic effects of chloramphenicol analogues”. Molecular Pharmacology 11 (1975): 520-527.
  11. Yunis AA. “Chloramphenicol toxicity”. In R. H. Girdwood (ed.), Blood disorders due to drugs and other agents. Excerpta Medica, Amsterdam (1974): 107-126.
  12. Wallerstein RO., et al. “State-wide study of chloramphenicol therapy and fatal aplastic anemia”. JAMA 208 (1969): 2045.
  13. Robert E Scully., et al. “Case records of the Massachusetts general hospital”. The New England Journal of Medicine 310 (1984).
×

Citation

Citation: Saidulu Ghanta., et al. “A Case Presentation on Chloramphenicol Induced Pancytopenia”. Acta Scientific Pharmacology 1.4 (2020).



News and Events


  • Certification for Review
    Acta Scientific certifies the Editors/reviewers for their review done towards the assigned articles of the respective journals.
  • Submission Timeline for Upcoming Issue
    The last date for submission of articles for regular Issues is December 15, 2020.
  • Publication Certificate
    Authors will be issued a "Publication Certificate" as a mark of appreciation for publishing their work.
  • Best Article of the Issue
    The Editors will elect one Best Article after each issue release. The authors of this article will be provided with a certificate of “Best Article of the Issue”.
  • Welcoming Article Submission
    Acta Scientific delightfully welcomes active researchers for submission of articles towards the upcoming issue of respective journals.
  • Contact US